TISSIUM
Ruth Krestin is the VP of Portfolio Strategy at Tissium. Ruth has over 11 years of experience in the pharma industry. After starting her career in strategy consulting at PwC, Ruth most recently spent 6 years at AstraZeneca, holding roles of increasing responsibility in both R&D and commercial, including portfolio management, business insights, and competitive intelligence. Ruth holds an MSc in Technology Policy from MIT and a BSc in Life Science from University College Utrecht.
This person is not in any teams
This person is not in any offices
TISSIUM
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.